These conclusions from rodents are supported by studies of Bartter and Gitelman syndromes (BS/GS) patients, where there is endogenous antagonism of AT1R signalling that in many respects resemble inhibition by losartan (e.g. Ang II elevation) [38, 39]. The gene discussed is AGT; the disease is Gerstmann syndrome.